On Friday, Jabil Circuit, Inc. (NYSE:JBL)’s shares declined -0.96% to $19.70.
Jabil Circuit, Inc. (JBL) declared that its Board of Directors has authorized the repurchase of up to $100 million worth of shares of the Company’s common stock during the period from recently through August 31, 2016. The shares will be repurchased from time-to-time in the open market at the Company’s discretion and subject to market conditions and other factors.
Jabil Circuit, Inc., together with its auxiliaries, provides electronic manufacturing services and solutions worldwide. It offers electronics design, production, and product administration services to companies in the aerospace, automotive, computing, defense, digital home, energy, healthcare, industrial, instrumentation, lifestyles, mobility, mold, networking, packaging, peripherals, storage, telecommunications, and wearable technology industries.
CNO Financial Group Inc (NYSE:CNO)’s shares dropped -1.18% to $17.55.
CNO Financial Group, Inc. (CNO) declared second quarter of 2015 operating earnings (1) of $60.8 million, or 31 cents per diluted share, contrast to $71.3 million, or 32 cents per diluted share, in the second quarter of 2014.
Second Quarter 2015 Highlights
- Sales, as defined by total new annualized premium (“NAP”) (2): $105.5 million, up 1% from 2Q14
- Collected premium from our ongoing operating segments (3): $830.9 million down slightly from 2Q14
- Net income per diluted share: 24 cents in 2Q15 (counting 11 cents from the loss on extinguishment of debt) contrast to 35 cents in 2Q14
- Net operating income (1) per diluted share: 31 cents in 2Q15 contrast to 32 cents in 2Q14
- Unrestricted cash and investments held by our holding company were $385 million at June 30, 2015
- Common stock repurchases and dividends were $115 million in 2Q15
CNO Financial Group, Inc., through its auxiliaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. Its Bankers Life segment markets and distributes Medicare supplement insurance, interest sensitive and traditional life insurance, fixed annuities, and long term care insurance products; Medicare advantage plans primarily through distribution arrangements with Humana, Inc. and United HealthCare; and Medicare Part D prescription drug plans through a distribution and reinsurance arrangement with Coventry Health Care.
At the end of Friday’s trade, Sensata Technologies Holding N.V. (NYSE:ST)‘s shares dipped -1.57% to $50.28.
Sensata Technologies Holding N.V. (ST) declares results of its operations for the second quarter ended June 30, 2015.
Highlights of the Three and Six Months ended June 30, 2015
Net revenue for the second quarter 2015 was $770.4 million, an enhance of $194.6 million, or 33.8%, from $575.9 million for the second quarter 2014. Net income for the second quarter 2015 was $40.9 million, or $0.24 per diluted share. This compares to Net income for the second quarter 2014 of $63.9 million, or $0.37 per diluted share. Adjusted net income1 for the second quarter 2015 was $124.6 million which was 16.2% of Net revenue, or $0.73 per diluted share. This was an enhance of 16.6% contrast to Adjusted net income1 for the second quarter 2014 of $106.8 million which was 18.6% of Net revenue, or $0.62 per diluted share. Integration charges related to acquisitions were $4.2 million for the second quarter of 2015.
Sensata Technologies Holding N.V., through its auxiliaries, develops, manufactures, and sells sensors and controls. It operates in two segments, Sensors and Controls. The Sensors segment manufactures pressure, temperature, speed, position, and force sensors, in addition to electromechanical sensors. Its products are used in subsystems of automobiles, such as engine, air conditioning, and ride stabilization; heavy off-road vehicles; and systems that address safety and environmental concerns.
Axcelis Technologies Inc (NASDAQ:ACLS), ended its Friday’s trading session with 0.94% gain, and closed at $3.21.
Axcelis Technologies, Inc. (ACLS) declared financial results for the second quarter ended June 30, 2015. Recent highlights comprise:
- Revenues of $78.4 million, a 7% enhance over the first quarter.
- Operating profit of $7.2 million, a 108.5% enhance over the first quarter.
- Improved gross margin to 34.6% from 31.9% in the first quarter.
- Raised cash and cash equivalents to $78.1 million from $74.5 million in the first quarter.
The Company stated second quarter revenue of $78.4 million, contrast to $73.3 million for the first quarter of 2015. Operating profit for the quarter was $7.2 million, contrast to $3.4 million for the first quarter. Net income for the quarter was $5.9 million, or $0.05 per share. This compares to net income for the first quarter of 2015 of $1.9 million, or $0.02 per share. Cash and cash equivalents was $78.1 million at June 30, 2015, contrast to $74.5 million on March 31, 2015.
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. It provides offers a line of high energy, high current, and medium current implanters for all application requirements.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
